Literature DB >> 26800999

Diagnostic performance of MRI for prediction of candidates for local excision of rectal cancer (ypT0-1N0) after neoadjuvant chemoradiation therapy.

Jun Gon Kim1, Kyoung Doo Song1, Seong Hyun Kim1, Hee Cheol Kim2, Jung Wook Huh2.   

Abstract

PURPOSE: To evaluate the diagnostic performance of rectal MRI in predicting candidates for local excision (LE; ypT0-1N0) after neoadjuvant chemoradiation therapy (CRT) in patients with rectal cancer.
MATERIALS AND METHODS: The institutional review board approved our retrospective study and waived informed consent. Inclusion criteria were as follows: patients with pathologically confirmed mid to lower rectal cancer (cT3NxM0 before neoadjuvant CRT) who underwent neoadjuvant CRT and had MRI performed at 3T before and after neoadjuvant CRT. A total of 168 patients met the study criteria between 2011 and 2012. Two observers independently assessed tumor and nodal stages on MR images obtained after neoadjuvant CRT. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy for identifying a candidate for LE (ypT0-1N0) were calculated. Interobserver agreement was assessed with kappa value. Predictive factors for ypT0-1N0 were evaluated by logistic regression models.
RESULTS: MRI had relatively high accuracy, specificity, and NPV (85.9%, 93.8%, and 88.9% for observer 1 and 85.3%, 96.1%, and 86.6% for observer 2), moderate PPV (71.4% and 76.2%), and relatively low sensitivity (57.1% and 45.7%) for predicting ypT0-1N0. The interobserver agreement was fair (kappa value = 0.593). Carcinoembryonic antigen levels after neoadjuvant CRT and the maximal extramural depth of tumor spread were significant predictors of ypT0-1N0 (P = 0.037 and 0.017, respectively).
CONCLUSION: MRI after neoadjuvant CRT can predict a candidate for LE (ypT0-1N0) after neoadjuvant CRT with moderate PPV and relatively high NPV. J. Magn. Reson. Imaging 2016;44:471-477.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  local excision; magnetic resonance imaging; neoadjuvant chemoradiation therapy; rectal cancer

Mesh:

Year:  2016        PMID: 26800999     DOI: 10.1002/jmri.25165

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  4 in total

1.  Indistinguishable T2/T3-N0 rectal cancer on rectal magnetic resonance imaging: comparison of surgery-first and neoadjuvant chemoradiation therapy-first strategies.

Authors:  Jun Gon Kim; Kyoung Doo Song; Dong Ik Cha; Hee Cheol Kim; Jeong Il Yu
Journal:  Int J Colorectal Dis       Date:  2018-07-13       Impact factor: 2.571

Review 2.  Response Assessment with MRI after Chemoradiotherapy in Rectal Cancer: Current Evidences.

Authors:  Nieun Seo; Honsoul Kim; Min Soo Cho; Joon Seok Lim
Journal:  Korean J Radiol       Date:  2019-07       Impact factor: 3.500

3.  Optimized Parameters of Diffusion-Weighted MRI for Prediction of the Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.

Authors:  Jie Li; Jia Wang; Jing Pang; Shougen Cao; Jingjing Chen; Wenjian Xu
Journal:  Biomed Res Int       Date:  2019-10-13       Impact factor: 3.411

4.  Prediction of pathological nodal stage of locally advanced rectal cancer by collective features of multiple lymph nodes in magnetic resonance images before and after neoadjuvant chemoradiotherapy.

Authors:  Haitao Zhu; Xiaoyan Zhang; Xiaoting Li; Yanjie Shi; Huici Zhu; Yingshi Sun
Journal:  Chin J Cancer Res       Date:  2019-12       Impact factor: 5.087

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.